ANNE GRIFFIN TAFEL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LEXINGTON, SC NPI 1609548171

General Payments — all program years on this page

$1,275.86

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $386.61 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $386.6121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $682.1825
2023 $207.0714
2024 $386.6121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100265412 Novo Nordisk Inc $17.34 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100348186 Novo Nordisk Inc $23.83 08/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100505157 Novo Nordisk Inc $19.58 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100526789 Novo Nordisk Inc $23.65 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100615065 Novo Nordisk Inc $21.69 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104551916 AstraZeneca Pharmaceuticals LP $14.56 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104674057 AstraZeneca Pharmaceuticals LP $14.48 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108282387 ABBVIE INC. $16.72 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108282389 ABBVIE INC. $24.51 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108282391 ABBVIE INC. $15.20 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108282393 ABBVIE INC. $19.82 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114461396 Exact Sciences Corporation $18.99 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114461402 Exact Sciences Corporation $18.50 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117751037 Corcept Therapeutics $16.20 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125150022 Abbott Laboratories $15.64 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125150024 Abbott Laboratories $20.92 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131830185 PFIZER INC. $13.32 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135475714 Lilly USA, LLC $15.49 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143613288 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.03 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153456961 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.39 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153468425 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.75 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.